Study guide
4.2 Biochemical Assessment, Visceral Proteins & Inflammation
Certified Nutrition Support Clinician CNSC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Nutrition Screening, Dietary Evaluation & Energy Requirements
1.1 Nutrition Screening & Validated Risk Tools 1.2 Dietary History & Nutrient Intake Assessment 1.3 Energy Expenditure Estimation & Indirect Calorimetry
2 Chapter 2: Macronutrients, Micronutrients & Fluid Management
2.1 Protein Requirements & Nitrogen Balance 2.2 Fluid Requirements & Electrolyte Homeostasis 2.3 Essential Vitamins & Trace Elements
3 Chapter 3: Anthropometrics, Physical Exam & Malnutrition Consensus
3.1 Anthropometric Assessment & Body Composition 3.2 Nutrition-Focused Physical Examination (NFPE) 3.3 AND/ASPEN & GLIM Malnutrition Criteria
4 Chapter 4: Pediatric & Specialized Nutrition Assessment
4.1 Pediatric & Neonatal Nutrition Assessment 4.2 Biochemical Assessment, Visceral Proteins & Inflammation
5 Chapter 5: Enteral Nutrition Access & Tube Management
5.1 Enteral Access Modalities & Route Selection 5.2 Tube Placement Verification & Stoma Site Care
6 Chapter 6: Enteral Formulation, Regimen Design & Administration
6.1 Enteral Formula Classification & Selection 6.2 Enteral Delivery Methods & Infusion Schedules 6.3 Enteral Fluid Management & Free Water Requirements
7 Chapter 7: Enteral Complications & Medication Administration
7.1 Enteral Gastrointestinal Complications 7.2 Enteral Metabolic, Mechanical & Pulmonary Complications 7.3 Drug-Nutrient Interactions & Enteral Medication Delivery
8 Chapter 8: Parenteral Nutrition Indications, Access & Formulation Design
8.1 Parenteral Nutrition Indications & Venous Access Routes 8.2 Peripheral Parenteral Nutrition (PPN) Parameters 8.3 Central PN Macronutrient Formulation
9 Chapter 9: Parenteral Additives, Compounding & Physical Stability
9.1 Parenteral Electrolytes, Trace Elements & Vitamins 9.2 Calcium-Phosphate Solubility & Precipitation Risks 9.3 Physical Stability, Total Nutrient Admixtures & Filtration
10 Chapter 10: Parenteral Complications, CLABSI & Organ Toxicities
10.1 Central Line-Associated Bloodstream Infections & Mechanical Risks 10.2 Refeeding Syndrome Pathophysiology & Prevention 10.3 Parenteral Nutrition-Associated Liver Disease & Metabolic Bone Disease
11 Chapter 11: Critical Care, Obesity & Pulmonary Nutrition Support
11.1 Critical Illness, Sepsis & Trauma Nutrition 11.2 Nutrition Support in Obesity & Hypocaloric Feeding 11.3 Pulmonary Failure & Mechanical Ventilation 11.4 Nutrition Support Care Plans, Goals & Therapy Reassessment
12 Chapter 12: Organ Failure: Renal, Hepatic & Gastrointestinal Support
12.1 Acute Kidney Injury & Renal Replacement Therapy 12.2 Cirrhosis, Hepatic Encephalopathy & Acute Pancreatitis 12.3 Short Bowel Syndrome & Intestinal Failure
13 Chapter 13: Oncology, Surgical Care & Intestinal Failure
13.1 Oncology Nutrition & Cancer Cachexia 13.2 Perioperative Nutrition & Enhanced Recovery After Surgery (ERAS) 13.3 Enterocutaneous Fistulas & Severe Malabsorption
14 Chapter 14: Process Management, Compounding Safety & Home Nutrition Support
14.1 PN Order Verification, Compounding Safety & USP Standards 14.2 Home Nutrition Support (HNS) & Care Transitions 14.3 Nutrition Support Policies, Product Shortages & Patient Education
15 Chapter 15: Professional Practice, Ethics & Interdisciplinary Care
15.1 Ethical Principles & Withholding/Withdrawing Artificial Nutrition 15.2 The Interdisciplinary Nutrition Support Team 15.3 Quality Improvement, Malnutrition Documentation & Clinical Standards 15.4 Critical Appraisal of Nutrition Research & Evidence
4.2 Biochemical Assessment, Visceral Proteins & Inflammation
Key Takeaways Explain This Topic AI
Traditional visceral proteins (albumin, prealbumin, transferrin, retinol-binding protein) reflect hepatic acute-phase reprioritization and capillary leak rather than somatic protein stores or nutrition support efficacy.
Systemic inflammation driven by pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha) downregulates hepatic gene transcription of negative acute-phase reactants while markedly upregulating positive acute-phase reactants such as C-reactive protein (CRP) and ferritin.
Increased microvascular permeability in critical illness accelerates transcapillary extravasation of serum albumin into interstitial third spaces, causing rapid drop in serum levels independent of nutrient intake.
Serial monitoring of the CRP-to-prealbumin trajectory identifies the opening of an anabolic window; a falling CRP (<10 mg/L) combined with a rising prealbumin indicates the resolution of systemic inflammation and the capacity for lean tissue accretion.
Nutrition support formulations directly influence systemic acid-base equilibrium: excess chloride in parenteral solutions provokes hyperchloremic normal anion gap metabolic acidosis (corrected by acetate substitution), whereas thiamine deficiency impairs pyruvate dehydrogenase, precipitating life-threatening high anion gap lactic acidosis.
Last updated: October 2026
4.2 Biochemical Assessment, Visceral Proteins & Inflammation
Clinical Core: Traditional visceral proteins—albumin, prealbumin, transferrin, and retinol-binding protein—are negative acute-phase reactants driven by systemic inflammation and capillary leak, not accurate measures of somatic protein mass or nutrition support efficacy. Nutrition clinicians must interpret visceral proteins alongside C-reactive protein to detect the opening of an anabolic window, while carefully managing fluid and electrolyte formulations to prevent and correct metabolic acid-base disorders in this independent study resource.
Visceral Protein Kinetics and Biological Distribution
For decades, circulating hepatic secretory proteins were mischaracterized as direct surrogates of nutritional status and muscle mass. Comprehensive clinical research has demonstrated that visceral protein serum concentrations are governed by intravascular distribution, transcapillary escape rates, hepatic synthesis reprioritization, and hydration status, rather than cellular nutrition stores.
Visceral Protein Biological Half-Life Normal Reference Range Total Body Pool Extravascular Distribution Primary Non-Nutritional Confounders
Albumin 18–20 days 3.5 – 5.0 g/dL 3.5\text{--}5.0\text{ g/dL} 3.5 – 5.0 g/dL 300 – 500 g 300\text{--}500\text{ g} 300 – 500 g ( 4 – 5 g/kg 4\text{--}5\text{ g/kg} 4 – 5 g/kg ) ∼ 60 % \sim 60\% ∼ 60% Systemic inflammation, capillary leak, fluid overload, liver failure, nephrotic syndrome, protein-losing enteropathy
Transferrin 8 days 200 – 400 mg/dL 200\text{--}400\text{ mg/dL} 200 – 400 mg/dL 8 – 10 g 8\text{--}10\text{ g} 8 – 10 g ∼ 50 % \sim 50\% ∼ 50% Iron deficiency anemia (falsely elevated), iron overload/hemochromatosis (falsely low), acute hepatitis, infection
Prealbumin (Transthyretin) 2–3 days 16 – 35 mg/dL 16\text{--}35\text{ mg/dL} 16 – 35 mg/dL ∼ 10 g \sim 10\text{ g} ∼ 10 g Minimal Systemic inflammation, acute surgical stress, end-stage liver disease; falsely elevated in acute/chronic renal failure
Retinol-Binding Protein (RBP) 10–12 hours 3 – 7 mg/dL 3\text{--}7\text{ mg/dL} 3 – 7 mg/dL < 2 g < 2\text{ g} < 2 g Minimal Acute kidney injury / ESRD (falsely elevated due to impaired tubular catabolism), vitamin A deficiency, zinc deficiency
Albumin Pharmacokinetics
Albumin is the most abundant circulating plasma protein, synthesized exclusively by hepatocytes at a baseline rate of approximately 10 to 15 g/day 10\text{ to }15\text{ g/day} 10 to 15 g/day . It accounts for roughly 75 % to 80 % 75\%\text{ to }80\% 75% to 80% of normal plasma oncotic pressure. Several key pharmacological and kinetic properties explain why albumin fails as an acute nutritional marker:
Prolonged Half-Life: With an elimination half-life of 18 to 20 days 18\text{ to }20\text{ days} 18 to 20 days , changes in dietary intake or amino acid infusion require several weeks to exert measurable changes on circulating serum concentrations.
Massive Extravascular Reservoir: Approximately 60 % 60\% 60% of the total exchangeable albumin pool resides extravascularly in the skin, interstitial fluid, and skeletal muscle. Under physiological conditions, albumin recirculates between the vascular and interstitial spaces via lymphatic drainage, with a normal transcapillary escape rate (TCER) of roughly 5 % per hour 5\%\text{ per hour} 5% per hour .
Buffering Capacity: During periods of uncomplicated dietary starvation, the body compensates by decreasing the rate of albumin degradation and recruiting extravascular albumin into the vascular space, maintaining normal serum albumin levels despite severe somatic wasting.
Prealbumin (Transthyretin)
Prealbumin is a transport glycoprotein that migrates anodal to albumin on serum protein electrophoresis. It forms a stable tetrameric complex with retinol-binding protein and circulates as a carrier for thyroxine ( T 4 T_4 T 4 ). Because of its short biological half-life of 2 to 3 days 2\text{ to }3\text{ days} 2 to 3 days and small body pool, prealbumin responds rapidly to changes in hepatic protein synthesis. However, it is an exquisite negative acute-phase reactant . The presence of even minor surgical trauma, wound infection, or localized tissue necrosis suppresses hepatic prealbumin transcription, rendering low levels non-diagnostic of malnutrition.
Transferrin and Retinol-Binding Protein
Transferrin: An iron-binding beta-globulin with an 8-day half-life. Transferrin synthesis is inversely linked to intracellular iron stores; in iron deficiency anemia, the liver upregulates transferrin synthesis to maximize iron scavenging, creating paradoxically high transferrin levels despite severe protein depletion. Conversely, iron overload states suppress transferrin synthesis.
Retinol-Binding Protein (RBP): Has an extremely rapid turnover with a half-life of 10 to 12 hours. It is filtered by renal glomeruli and metabolized by proximal tubular cells. In acute kidney injury or chronic renal failure, impaired renal tubular clearance causes dramatic elevations in serum RBP, masking severe clinical wasting. Furthermore, RBP requires both vitamin A and zinc for hepatic synthesis and release.
Acute Phase Response Pathophysiology & The Capillary Leak Phenomenon
When the human body sustains tissue trauma, invasive infection, severe burns, or critical illness, immune cells initiate a hypermetabolic systemic cascade known as the acute phase response . Sepsis / Trauma / Tissue Injury
- │
- ▼
- Activated Macrophages & Monocytes
- │
- ▼
- Pro-Inflammatory Cytokines
- (IL-1, IL-6, TNF-α)
- ┌────────┴────────┐
- ▼ ▼
- Hepatic Reprogramming Capillary Endothelium Breakdown
- │ │
- ┌────┴────┐ ▼
- ▼ ▼ VE-Cadherin Disruption &
- Negative Positive Glycocalyx Shedding
- (Albumin, (CRP, │
- Prealb) Ferritin) ▼
- Transcapillary Escape (TCER 5% ➔ 15%/hr)
- │
- ▼
- Interstitial Extravasation & Third-Spacing
- Hepatic Transcriptional Reprogramming
Pro-inflammatory cytokines—primarily Interleukin-1 (IL-1) , Interleukin-6 (IL-6) , and Tumor Necrosis Factor-alpha (TNF- α \alpha α ) —circulate to the liver and bind to hepatocyte surface receptors (such as the gp130/IL-6R signaling complex). This activates intracellular JAK-STAT3 and NF- κ B \kappa\text{B} κ B signal transduction cascades, fundamentally altering hepatic gene transcription:
Downregulation of Negative Acute-Phase Reactants: Hepatic transcription of mRNA for albumin, prealbumin, transferrin, and retinol-binding protein is profoundly suppressed.
Upregulation of Positive Acute-Phase Reactants: The liver prioritizes the mass production of protective and immunological proteins, including C-reactive protein (CRP) , serum amyloid A, alpha-1 acid glycoprotein, fibrinogen, ferritin, ceruloplasmin, and procalcitonin.
The Capillary Leak Phenomenon and Third-Spacing
Simultaneously, circulating TNF- α \alpha α , IL-1, and reactive oxygen species act on the microvascular endothelium. Cytokines disrupt vascular endothelial cadherin (VE-cadherin) adherens junctions and induce enzymatic shedding of the endothelial glycocalyx proteoglycan barrier.
This structural breakdown causes a dramatic spike in microvascular permeability. The transcapillary escape rate (TCER) of albumin surges from its normal 5 % per hour 5\%\text{ per hour} 5% per hour to upwards of 15 % to 20 % per hour 15\%\text{ to }20\%\text{ per hour} 15% to 20% per hour (a 300 % 300\% 300% increase). Intravascular albumin pours into the interstitial third spaces, pulling water along by oncotic force. The clinical consequence is profound peripheral edema, ascites, pleural effusions, and anasarca, accompanied by an abrupt, precipitous drop in circulating serum albumin and prealbumin within 24 to 48 hours of injury.
The Confounding Role of Fluid Resuscitation
In acute shock and sepsis, patients receive aggressive crystalloid volume resuscitation (e.g., liters of 0.9 % 0.9\% 0.9% normal saline or lactated Ringer's). This expansion of extracellular water produces severe hemodilution , further depressing serum visceral protein concentrations completely independent of the patient's nutritional state.
Why Visceral Proteins Cannot Be Used to Diagnose Malnutrition
The 2012 Academy of Nutrition and Dietetics / ASPEN consensus statement on adult malnutrition explicitly eliminated albumin, prealbumin, and other visceral proteins from the diagnostic criteria for malnutrition. The physiological dissociation between nutrition and visceral proteins is demonstrated across clinical extremes:
Pure Starvation Without Inflammation (e.g., Uncomplicated Anorexia Nervosa): Patients with severe anorexia nervosa or prolonged non-inflammatory starvation can lose 30 % to 40 % 30\%\text{ to }40\% 30% to 40% of total body weight, depleting nearly all subcutaneous adipose reserves and skeletal muscle. Yet, their serum albumin and prealbumin concentrations typically remain entirely within normal reference ranges until the terminal pre-mortem state because hepatic synthetic machinery is intact and no inflammatory cytokine signaling suppresses transcription or breaches the vascular endothelium.
Severe Inflammation Without Pre-Existing Malnutrition (e.g., Acute Trauma or Sepsis): A previously healthy, muscular young individual who suffers severe multi-trauma or septic shock will exhibit serum albumin levels dropping below 2.0 g/dL 2.0\text{ g/dL} 2.0 g/dL and prealbumin below 7 mg/dL 7\text{ mg/dL} 7 mg/dL within 48 hours. This individual is not malnourished; they are acutely hypermetabolic and inflamed.
The Danger of Using Visceral Proteins as Feeding Targets
Attempting to prescribe escalating calories or protein to "push up" a low serum albumin or prealbumin in an inflamed patient is fundamentally flawed and dangerous. During active systemic inflammation, exogenous amino acids cannot overcome cytokine-mediated hepatic transcriptional suppression. Aggressive overfeeding during this phase leads to severe clinical complications: hyperglycemia, hepatic steatosis, excessive carbon dioxide production ( V CO 2 V_{\text{CO}_2} V CO 2 ) precipitating respiratory failure, azotemia, and increased infectious morbidity .
Clinical Utility of the CRP / Prealbumin Trajectory and the Anabolic Window
While visceral proteins are invalid diagnostic markers for malnutrition, serial monitoring of prealbumin paired with C-reactive protein (CRP) provides valuable prognostic information regarding the resolution of systemic stress and the metabolic capacity for anabolism.
C-Reactive Protein (CRP) Kinetics
CRP is synthesized exclusively by hepatocytes under the direct influence of IL-6. It has an elimination half-life of approximately 19 hours 19\text{ hours} 19 hours , which remains constant across health and disease. Serum CRP levels begin rising within 4 to 6 hours of an inflammatory insult, peak between 36 and 50 hours, and can surge from a normal baseline ( < 3 – 5 mg/L < 3\text{--}5\text{ mg/L} < 3 – 5 mg/L ) to over 150 to 300 mg/L 150\text{ to }300\text{ mg/L} 150 to 300 mg/L in severe sepsis.
The Anabolic Window Concept
Because CRP clears rapidly as inflammation subsides, tracking the concurrent trajectory of CRP and prealbumin enables the clinician to identify when a patient transitions from systemic catabolism to anabolism:
Active Inflammatory / Catabolic Phase: Markedly elevated CRP ( > 50 – 100 mg/L > 50\text{--}100\text{ mg/L} > 50 – 100 mg/L ) with severely depressed prealbumin ( < 10 mg/dL < 10\text{ mg/dL} < 10 mg/dL ). The patient is in the throes of systemic inflammation. Providing hypocaloric/trophic nutrition support (e.g., 12 – 15 kcal/kg/day 12\text{--}15\text{ kcal/kg/day} 12 – 15 kcal/kg/day or 50 % – 70 % 50\%\text{--}70\% 50% – 70% of needs with targeted protein) prevents feeding-related complications while meeting basal demands.
The Anabolic Window: As the underlying pathology is controlled (abscess drained, antibiotics effective, surgical wounds healing), CRP concentrations plummet below 10 to 20 mg/L 10\text{ to }20\text{ mg/L} 10 to 20 mg/L . The inhibitory cytokine brake on the hepatocyte is released, allowing hepatic prealbumin transcription to rebound.
Assessing Nutritional Anabolism: Once CRP is < 10 mg/L < 10\text{ mg/L} < 10 mg/L , a sustained rise in prealbumin of ≥ 2 mg/dL/day \ge 2\text{ mg/dL/day} ≥ 2 mg/dL/day (or > 4 mg/dL/week > 4\text{ mg/dL/week} > 4 mg/dL/week ) confirms that the patient has entered an anabolic window . In this phase, advancing caloric and nitrogen delivery directly promotes positive nitrogen balance, somatic protein synthesis, and lean tissue accretion.
Acid-Base Disturbances in Nutrition Support
Nutrition support clinicians frequently manage complex fluid, electrolyte, and acid-base derangements. Understanding the pathophysiology of metabolic acidosis and metabolic alkalosis is critical for safe enteral and parenteral prescription design.
Henderson-Hasselbalch Framework and Anion Gap
pH = 6.1 + log ( [ HCO 3 − ] 0.03 × P CO 2 ) \text{pH} = 6.1 + \log\left(\frac{[\text{HCO}_3^-]}{0.03 \times P_{\text{CO}_2}}\right) pH = 6.1 + lo g ( 0.03 × P CO 2 [ HCO 3 − ] )
Serum Anion Gap = [ Na + ] − ( [ Cl − ] + [ HCO 3 − ] ) \text{Serum Anion Gap} = [\text{Na}^+] - ([\text{Cl}^-] + [\text{HCO}_3^-]) Serum Anion Gap = [ Na + ] − ([ Cl − ] + [ HCO 3 − ])
Normal Anion Gap: 8 to 12 mEq/L 8\text{ to }12\text{ mEq/L} 8 to 12 mEq/L (reflecting unmeasured circulating anions, predominantly albumin and organic phosphates).
1. Metabolic Acidosis
Metabolic acidosis is characterized by a primary reduction in serum bicarbonate ( [ HCO 3 − ] < 22 mEq/L [\text{HCO}_3^-] < 22\text{ mEq/L} [ HCO 3 − ] < 22 mEq/L ) and a secondary compensatory decrease in P CO 2 P_{\text{CO}_2} P CO 2 via respiratory hyperventilation.
A. Normal Anion Gap (Hyperchloremic) Metabolic Acidosis
Pathophysiology: In normal anion gap acidosis, the decrease in bicarbonate is matched by an equimolar increase in serum chloride to maintain electroneutrality ( [ Cl − ] > 106 mEq/L [\text{Cl}^-] > 106\text{ mEq/L} [ Cl − ] > 106 mEq/L ), keeping the anion gap between 8 8 8 and 12 mEq/L 12\text{ mEq/L} 12 mEq/L .
Etiologies in Nutrition Support:
Excessive Parenteral Chloride Administration: Standard crystalline amino acid solutions contain basic amino acids (lysine, arginine, histidine) that are often formulated as chloride salts. If the clinician orders electrolytes primarily as chloride salts (e.g., sodium chloride and potassium chloride) rather than acetate salts, hyperchloremic metabolic acidosis rapidly ensues.
High-Volume Normal Saline Infusions: 0.9 % NaCl 0.9\%\text{ NaCl} 0.9% NaCl has a chloride concentration of 154 mEq/L 154\text{ mEq/L} 154 mEq/L , far exceeding physiological plasma chloride ( 100 – 106 mEq/L 100\text{--}106\text{ mEq/L} 100 – 106 mEq/L ).
Gastrointestinal Bicarbonate Losses: High-output enterocutaneous fistulae, biliary drains, pancreatic drainage, or severe secretory diarrhea result in the massive loss of alkaline secretions rich in bicarbonate.
Management: Convert chloride salts in the parenteral nutrition solution to acetate salts (sodium acetate and potassium acetate). Acetate is metabolized in equimolar proportions to bicarbonate via acetyl-CoA oxidation in the liver and peripheral tissues (primarily skeletal muscle), rapidly restoring serum bicarbonate balance.
B. High Anion Gap Metabolic Acidosis (AG > 12 mEq/L > 12\text{ mEq/L} > 12 mEq/L )
Pathophysiology: Accumulation of unmeasured endogenous organic acids (lactate, acetoacetate, beta-hydroxybutyrate) or exogenous toxins.
Etiology in Nutrition Support — Thiamine Deficiency Lactic Acidosis:
Mechanism: Thiamine pyrophosphate (TPP) is an indispensable cofactor for the pyruvate dehydrogenase (PDH) complex , which catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA for entry into the mitochondrial Krebs (citric acid) cycle.
Precipitating Event: Providing high-dextrose parenteral or enteral nutrition to severely malnourished patients, individuals with alcohol use disorder, post-bariatric surgery patients, or during national intravenous multivitamin shortages without thiamine supplementation.
Pathophysiology: Massive glucose loading dramatically increases glycolytic flux, depleting residual cellular thiamine. In the absence of TPP, pyruvate cannot enter the Krebs cycle and is rapidly shunted by lactate dehydrogenase (LDH) into L-lactic acid .
Clinical Presentation: Refractory, life-threatening lactic acidosis (arterial lactate frequently > 10 – 15 mmol/L > 10\text{--}15\text{ mmol/L} > 10 – 15 mmol/L , anion gap > 20 – 30 mEq/L > 20\text{--}30\text{ mEq/L} > 20 – 30 mEq/L ), hemodynamic instability, and circulatory shock refractory to catecholamines.
Management: Immediate administration of high-dose intravenous thiamine ( 200 – 500 mg 200\text{--}500\text{ mg} 200 – 500 mg IV every 8 hours) rapidly reactivates PDH, clearing serum lactate within hours.
2. Metabolic Alkalosis
Metabolic alkalosis is characterized by an elevated serum bicarbonate ( [ HCO 3 − ] > 26 mEq/L [\text{HCO}_3^-] > 26\text{ mEq/L} [ HCO 3 − ] > 26 mEq/L ) and an elevated arterial pH ( > 7.45 > 7.45 > 7.45 ).
Hypokalemic, Hypochloremic Metabolic Alkalosis
Pathophysiology: Loss of gastric hydrochloric acid ( HCl \text{HCl} HCl ) and potassium from prolonged nasogastric suction, severe vomiting, or continuous gastrostomy tube drainage. Loop diuretics (e.g., furosemide) worsen this by inhibiting the renal Na + − K + − 2 Cl − \text{Na}^+-\text{K}^+-2\text{Cl}^- Na + − K + − 2 Cl − co-transporter in the thick ascending limb of Henle.
Renal Compensation and Paradoxical Aciduria:
Gastric HCl \text{HCl} HCl loss leads to unbuffered bicarbonate accumulation in plasma.
Concomitant hypovolemia stimulates the renin-angiotensin-aldosterone system (RAAS). High aldosterone levels act on the renal cortical collecting tubule to maximize sodium reabsorption.
Because chloride is depleted, the distal tubule must reabsorb sodium in exchange for secreting cations: potassium ( K + K^+ K + ) and hydrogen ( H + H^+ H + ) .
Accelerated urinary hydrogen ion secretion in the face of systemic alkalosis produces the classic clinical phenomenon of paradoxical aciduria , perpetuating the metabolic alkalosis.
Management in Nutrition Support:
Rehydrate with isotonic chloride-containing fluids to restore effective circulating arterial volume.
In parenteral nutrition, eliminate all acetate salts and provide sodium and potassium entirely as chloride salts (sodium chloride, potassium chloride).
Aggressively replete serum potassium, enabling the distal renal tubule to excrete potassium rather than hydrogen ions in exchange for sodium.